- Home
- LPCN vs VNCE Comparison
LPCN vs VNCE Comparison
Compare LPCN & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- VNCE
- Stock Information
- Founded
- LPCN 1997
- VNCE 2002
- Country
- LPCN United States
- VNCE United States
- Employees
- LPCN N/A
- VNCE N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- VNCE Clothing/Shoe/Accessory Stores
- Sector
- LPCN Health Care
- VNCE Consumer Discretionary
- Exchange
- LPCN Nasdaq
- VNCE Nasdaq
- Market Cap
- LPCN 18.2M
- VNCE 20.2M
- IPO Year
- LPCN N/A
- VNCE 2013
- Fundamental
- Price
- LPCN $3.19
- VNCE N/A
- Analyst Decision
- LPCN Strong Buy
- VNCE Strong Buy
- Analyst Count
- LPCN 1
- VNCE 4
- Target Price
- LPCN $8.00
- VNCE $4.63
- AVG Volume (30 Days)
- LPCN 45.3K
- VNCE 4.9M
- Earning Date
- LPCN 11-06-2025
- VNCE 09-10-2025
- Dividend Yield
- LPCN N/A
- VNCE N/A
- EPS Growth
- LPCN N/A
- VNCE N/A
- EPS
- LPCN N/A
- VNCE N/A
- Revenue
- LPCN $4,208,119.00
- VNCE $291,286,000.00
- Revenue This Year
- LPCN N/A
- VNCE $1.48
- Revenue Next Year
- LPCN N/A
- VNCE $4.92
- P/E Ratio
- LPCN N/A
- VNCE N/A
- Revenue Growth
- LPCN N/A
- VNCE N/A
- 52 Week Low
- LPCN $2.65
- VNCE $1.02
- 52 Week High
- LPCN $6.17
- VNCE $6.89
- Technical
- Relative Strength Index (RSI)
- LPCN 63.61
- VNCE 59.70
- Support Level
- LPCN $2.65
- VNCE $2.83
- Resistance Level
- LPCN $3.52
- VNCE $3.39
- Average True Range (ATR)
- LPCN 0.16
- VNCE 0.37
- MACD
- LPCN 0.06
- VNCE -0.05
- Stochastic Oscillator
- LPCN 67.24
- VNCE 52.33
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About VNCE Vince Holding Corp.
Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.